시장보고서
상품코드
1098620

브루셀라병 백신 시장 규모, 점유율, 전망, 기회(2022-2030년) : 종류(RB51 백신, S19 백신, B19 백신, 기타), 용도(소, 양, 염소, 기타), 지역별

Brucellosis Vaccines Market, by Type (RB51 Vaccine, S19 Vaccine, B19 Vaccine and Others ), by Application (Cattle, Sheep, Goat and Others ), and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

브루셀라병 유병률 증가가 예측기간 중 세계의 브루셀라병 백신 시장 성장을 촉진할 것으로 예상됩니다.

세계의 브루셀라병 백신(Brucellosis Vaccines) 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 대한 각종 영향요인 분석, 규제 상황, 시장 규모 추정과 예측, 각종 부문·지역/주요 국가별 내역, 경쟁 환경, 주요 기업 개요 등을 정리했습니다.

목차

제1장 조사 목적과 가정

제2장 시장 개요

제3장 시장 역학, 규제, 동향 분석

  • 성장 촉진요인
  • 성장 억제요인
  • 시장 기회
  • 영향 분석
  • 시장 동향
  • 주요 전개
  • 제품 발매
  • 규제 가이드라인
  • 인수·제휴·협력
  • 역학
  • PEST 분석

제4장 세계의 브루셀라병 백신 시장 : COVID-19의 영향

  • 경제적 영향
  • 수요와 공급 분석

제5장 세계의 브루셀라병 백신 시장 : 종류별

  • RB51 백신
  • S19 백신
  • B19 백신
  • 기타(45/20 백신, SR82 백신 등)

제6장 세계의 브루셀라병 백신 시장 : 용도별

  • 염소
  • 기타(돼지, 말 등)

제7장 세계의 브루셀라병 백신 시장 : 지역별

  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제8장 경쟁 상황

  • 경쟁 현황
    • Merck &Co., Inc.
    • CZ Vaccines
    • Colorado Serum Company
    • Indian Immunologicals Ltd.
    • Hester Biosciences Limited
    • Veterinary Technologies Corporation
    • Jordan Bio-industries Center
    • Laboratorios Tornel
    • Fivet Animal Health
    • VETAL Animal Health Products Inc.

제9장 섹션

KSM 22.07.15

Brucellosis is an infectious disease caused by bacteria. Animals that are most commonly infected include sheep, cattle, goats, pigs, and dogs, among others. These disease can also occur in humans when they are in contact with infected animals or animal products contaminated with bacteria.

Moreover, RB51 Vaccine, S19 Vaccine, B19 Vaccine and Others (45/20 vaccine, SR82 vaccine, etc.) are the type of vaccine used for the brucellosis in animals.

Furthermore, increasing launches of brucellosis vaccination programmes is expected to drive the market growth over the forecast period.

In August 2021, brucella vaccination program was launched at Thoubal, Manipur, India for the control and eradication of brucellosis in female calves of 4-8 months age group.

Market Dynamics

Increasing prevalence of brucellosis is expected to drive the global brucellosis vaccines market growth over the forecast period. For instance, according to an article published by the National Center for Biotechnology Information, a series of databases relevant to biotechnology and biomedicine, brucellosis is the world's most widespread zoonotic disease, a type of disease that passes from an animal to a human. The source stated that there are a reported 500,000 cases of human brucellosis each year, globally. However, true incidence is estimated to be 5,000,000 to 12,500,000 cases each year, globally.

According to the same source, brucellosis is recognized as the world's most common laboratory-acquired infection.

Key features of the study:

  • This report provides an in-depth analysis of the global brucellosis vaccines market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global brucellosis vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Merck & Co., Inc., CZ Vaccines, Colorado Serum Company, Indian Immunologicals Ltd., Hester Biosciences Limited, Veterinary Technologies Corporation, Jordan Bio-industries Center, Laboratorios Tornel, Fivet Animal Health and VETAL Animal Health Products Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global brucellosis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global brucellosis vaccines market

Detailed Segmentation:

  • Global Brucellosis Vaccines Market, By Type:
    • RB51 Vaccine
    • S19 Vaccine
    • B19 Vaccine
    • Others (45/20 vaccine, SR82 vaccine, etc.)
  • Global Brucellosis Vaccines Market, By Application:
    • Cattle
    • Sheep
    • Goat
    • Others (swine, horses, etc.)
  • Global Brucellosis Vaccines Market, By Region:
    • North America
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Competitive Snapshot
      • Merck & Co., Inc.*
      • Company Overview
      • Application Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
      • CZ Vaccines
      • Colorado Serum Company
      • Indian Immunologicals Ltd.
      • Hester Biosciences Limited
      • Veterinary Technologies Corporation
      • Jordan Bio-industries Center
      • Laboratorios Tornel
      • Fivet Animal Health
      • VETAL Animal Health Products Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Launch
  • Regulatory Guidelines
  • Acquisitions, Collaborations, & Partnerships
  • Epidemiology
  • PEST Analysis

4. Global Brucellosis Vaccines Market - Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • Supply and Demand Analysis

5. Global Brucellosis Vaccines Market, By Type, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • RB51 Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • S19 Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • B19 Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Others (45/20 vaccine, SR82 vaccine, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Brucellosis Vaccines Market, By Application, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Cattle
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Sheep
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Goat
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Others (swine, horses, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Global Brucellosis Vaccines Market, By Region, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
  • North America
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Region/Country, 2017 - 2030, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Competitive Snapshot
    • Merck & Co., Inc.*
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CZ Vaccines
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Colorado Serum Company
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Indian Immunologicals Ltd.
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hester Biosciences Limited
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Veterinary Technologies Corporation
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Jordan Bio-industries Center
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Laboratorios Tornel
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Fivet Animal Health
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • VETAL Animal Health Products Inc.
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제